Publication at Faculty of Medicine in Pilsen |
2013
Abstract
Authors presented a case report of NSCLC patient suffering from generalized pulmonary adenocarcinoma after a failure of I.st. line chemotherapy, 15 months lasting partial remission was actieved on crizotinib therapy.